Results 241 to 250 of about 578,033 (291)

Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning. [PDF]

Front Immunol
Wang M, Qian Y, Huang E, Chu C, Gao T, Chen S, Zhao N, Luo C, Liu Y, Zheng X, Hu H, Han B, Chen M, Mao W, Li W.   +14 more
europepmc   +1 more source

Rocket‐Inspired Sequentially Targeted Nanotherapeutics for Mitochondrial Regulation and Inflammatory Reprogramming in Ischemic Stroke

Advanced Science, EarlyView.
A novel neutrophil‐hitchhiking, rocket‐inspired nanoplatform is developed to cross the blood‐brain barrier for sequential, spatiotemporal drug delivery. By responsive surface transformation in the ischemic penumbra, it precisely targets mitochondria to suppress Drp1‐mediated fission.
He Bai, Zihao Yong, Yang Li, Qingmin Chen, Yong Liu, Xiaomeng Guo, Fukai Li, Shicheng Tang, Zhuo Yang, Yufei Zhang, Ruwei Jie, Xiaohong Lv, Huacheng Wang, Chunming Huang, Liwei Xie, Jianqi Xiao, Qingchun Mu, Longguang Tang   +17 more
wiley   +1 more source

Innovative Test Strip‐Based Colorimetric Sensors Integrated With Affinity Chromatography: Acetylcholinesterase Inhibitor Screening Breakthrough in Lycium Barbarum Leaves

Advanced Science, EarlyView.
Schematic diagrams illustrating the breakthrough in the screening of AChE inhibitors from LBL, and the research process of the pharmacodynamics of the NCP are presented. ABSTRACT Current Alzheimer's drugs exhibit limited effectiveness, highlighting the necessity for multi‐target treatments.
Yuping Sa, Hui Yuan, Jingui Ma, Zhigang Yang, Mei Wang, Weibiao Wang, Lingling Yang, Fen Ma, Weiman Zhang, Gidion Wilson Mening'oo, Guoning Chen, Xueqin Ma   +11 more
wiley   +1 more source

18 β-Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN/PI3K/mTOR Pathway. [PDF]

Clin Exp Pharmacol Physiol
Xiong D, Dai H.
europepmc   +1 more source

Comparative Analysis of Alcohol and Aldehyde Dehydrogenase Activities in Prostate Cancer and Benign Prostatic Hyperplasia. [PDF]

J Clin Med
Nowiński AR, Jelski W, Skrodzka M, Mroczko B, Gryko M, Orywal K.   +5 more
europepmc   +1 more source

SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer. [PDF]

J Biochem Mol Toxicol
Liu P, Zhang H, Qian Y, Zhang J, Deng X, Sun B.   +5 more
europepmc   +1 more source

Combining PSA density and imaging data with transcript markers from urinary cells to improve prediction of prostate cancer reclassification in patients on active surveillance. [PDF]

BJUI Compass
Borkowetz A, Gräfe S, Kwe J, Fuessel S, Thomas C, Erdmann K.   +5 more
europepmc   +1 more source

ATP-dependent chromatin remodelers in prostate cancer progression and therapeutic resistance.

Endocrinology
Torres LM, Yates C, Bevan CL, Freeman MR, Campbell MJ.   +4 more
europepmc   +1 more source